HomeHRTX • NASDAQ
add
Heron Therapeutics Inc
Previous close
$1.06
Day range
$1.06 - $1.10
Year range
$1.04 - $3.93
Market cap
162.28M USD
Avg Volume
1.83M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 32.81M | 4.38% |
Operating expense | 23.34M | -19.14% |
Net income | -4.85M | 80.61% |
Net profit margin | -14.78 | 81.42% |
Earnings per share | -0.03 | 82.35% |
EBITDA | -3.88M | 83.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.89M | -8.43% |
Total assets | 220.78M | -3.67% |
Total liabilities | 260.78M | 1.48% |
Total equity | -40.00M | — |
Shares outstanding | 152.09M | — |
Price to book | -4.08 | — |
Return on assets | -5.08% | — |
Return on capital | -7.99% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.85M | 80.61% |
Cash from operations | 3.37M | 136.73% |
Cash from investing | 3.97M | 117.10% |
Cash from financing | 14.00K | -99.97% |
Net change in cash | 7.36M | -65.63% |
Free cash flow | 4.60M | 485.39% |
About
Founded
1983
Headquarters
Website
Employees
126
